US President Trump’s rapid-fire executive orders, many of which impact the medtech sector, have sparked a range of reactions and concerns among European device and diagnostic stakeholders. This has highlighted the interconnectedness of global regulatory environments and the need for Europe to urgently rethink its position.
Key Takeaways
- Trump's deregulation may outpace the EU, causing business apprehension and international friction.
Trump’s overriding goal is deregulation. He believes the EU has too many rules and the US government needs to rethink...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?